Action	Date	Notes	Link
article xml file uploaded	7 February 2021 13:07 CET	Original file	-
article xml uploaded.	7 February 2021 13:07 CET	Update	-
article pdf uploaded.	7 February 2021 13:07 CET	Version of Record	https://www.mdpi.com/2072-6694/13/4/672/pdf-vor
article supplementary file uploaded.	7 February 2021 13:07 CET	-	https://www.mdpi.com/2072-6694/13/4/672#supplementary
article html file updated	7 February 2021 13:08 CET	Original file	-
article html file updated	24 July 2022 19:10 CEST	Update	-
article pdf uploaded.	3 March 2025 10:03 CET	Updated version of record	https://www.mdpi.com/2072-6694/13/4/672/pdf
article xml uploaded.	3 March 2025 10:03 CET	Update	https://www.mdpi.com/2072-6694/13/4/672/xml
article html file updated	3 March 2025 10:07 CET	Update	https://www.mdpi.com/2072-6694/13/4/672/html

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Janssen, J.; Löwenberg, B.; Manz, M.; Bargetzi, M.; Biemond, B.; von dem Borne, P.; Breems, D.; Brouwer, R.; Chalandon, Y.; Deeren, D.; et al. Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers 2021, 13, 672. https://doi.org/10.3390/cancers13040672

AMA Style

Janssen J, Löwenberg B, Manz M, Bargetzi M, Biemond B, von dem Borne P, Breems D, Brouwer R, Chalandon Y, Deeren D, et al. Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers. 2021; 13(4):672. https://doi.org/10.3390/cancers13040672

Chicago/Turabian Style

Janssen, Jeroen, Bob Löwenberg, Markus Manz, Mario Bargetzi, Bart Biemond, Peter von dem Borne, Dimitri Breems, Rolf Brouwer, Yves Chalandon, Dries Deeren, and et al. 2021. "Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS" Cancers 13, no. 4: 672. https://doi.org/10.3390/cancers13040672

APA Style

Janssen, J., Löwenberg, B., Manz, M., Bargetzi, M., Biemond, B., von dem Borne, P., Breems, D., Brouwer, R., Chalandon, Y., Deeren, D., Efthymiou, A., Gjertsen, B.-T., Graux, C., Gregor, M., Heim, D., Hess, U., Hoogendoorn, M., Jaspers, A., Jie, A., ... Ossenkoppele, G. (2021). Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers, 13(4), 672. https://doi.org/10.3390/cancers13040672

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI